Biosyent Inc BIOYF:OTCPK

*Data is delayed | Exchange | USD
Last | 05/07/24 EDT
6.33UNCH (UNCH)
52 week range
5.26 - 6.97
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.33
  • 52 Week High6.97
  • 52 Week High Date12/29/23
  • 52 Week Low5.26
  • 52 Week Low Date06/07/23

Key Stats

  • Market Cap74.81M
  • Shares Out11.8M
  • 10 Day Average Volume1,315.83
  • Dividend0.13
  • Dividend Yield2.10%
  • Beta-
  • YTD % Change-9.08

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.33
  • 52 Week High6.97
  • 52 Week High Date12/29/23
  • 52 Week Low5.26
  • 52 Week Low Date06/07/23
  • Market Cap74.81M
  • Shares Out11.8M
  • 10 Day Average Volume1,315.83
  • Dividend0.13
  • Dividend Yield2.10%
  • Beta-
  • YTD % Change-9.08

RATIOS/PROFITABILITY

  • EPS (TTM)0.40
  • P/E (TTM)15.76
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/28/2024
  • Div Amount0.045
  • Split Date-
  • Split Factor-

Latest On Biosyent Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include...
Rene Goehrum
Chairman of the Board, President, Chief Executive Officer
Robert March
Chief Financial Officer, Vice President - Finance
Joost Van Der Mark
Vice President- Corporate Development
Kevin Wilson
Vice President - Community Health Business
Address
2476 Argentia Road, Suite 402
Mississauga, ON
L5N 6M1
Canada